DHG Pharmaceutical

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
114,100 ^VND	+0.35%		+2.61%	+9.71%

Apr. 19	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 28	DHG Pharmaceutical Joint Stock Company Announces Resignation of Marketing Director Tran Duy Hung	CI

DHG Pharmaceutical Joint Stock Company Announces Change in Personnel

April 21, 2023 at 03:59 am EDT

DHG Pharmaceutical Joint Stock Company announces resignation of Masashi Nakaura and Doan dinh duy khuong as board member.

Latest news about DHG Pharmaceutical

DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
DHG Pharmaceutical Joint Stock Company Announces Resignation of Marketing Director Tran Duy Hung	Mar. 27	CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024	Jan. 19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 19	CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024	Jan. 02	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-20	CI
DHG Pharmaceutical Joint Stock Company Announces Change in Personnel	23-04-21	CI
DHG Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2022, Payable on May 12, 2023	23-04-21	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-19	CI
DHG Pharmaceutical Joint Stock Company Approves Executive Changes	22-12-04	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-18	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI
DHG Pharmaceutical Joint Stock Company Announces Cash Dividend for the for 2021, Payable on April 15, 2022	22-03-24	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-01-19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-19	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-21	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-19	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-21	CI
DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Year 2020	20-07-03	CI

DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for DHG Pharmaceutical

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

113,800 VND

Average target price

116,593 VND

Spread / Average Target

+2.45%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DHG PHARMACEUTICAL	+9.71%	586M
ELI LILLY AND COMPANY	+29.68%	681B
NOVO NORDISK A/S	+21.31%	556B
JOHNSON & JOHNSON	-4.35%	361B
MERCK & CO., INC.	+17.65%	325B
ABBVIE INC.	+3.77%	285B
ASTRAZENECA PLC	+13.64%	235B
NOVARTIS AG	+4.52%	199B
ROCHE HOLDING AG	-12.31%	189B
PFIZER, INC.	-3.79%	157B

Other Pharmaceuticals